港股异动 | 英硅智能(03696)尾盘涨超3% 与施维雅达成多年期抗肿瘤药物研发合作

智通财经01-06

智通财经APP获悉，英硅智能(03696)尾盘涨超3%，截至发稿，涨2.89%，报38.46港元，成交额1.11亿港元。消息面上，1月5日，英硅智能发布公告，集团已与一家由基金会管理的全球独立制药公司施维雅达成多年期研发合作。该合作价值高达8.88亿美元，将充分利用集团自主研发的人工智能平台Pharma.AI，聚焦于抗肿瘤领域具有挑战性的靶点，识别并开发全新的治疗药物。根据协议，集团将有资格获得...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2601886148?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-06 15:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601886148","market":"hk","top_or_hot":-1,"title":"港股异动 | 英硅智能(03696)尾盘涨超3% 与施维雅达成多年期抗肿瘤药物研发合作","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，英硅智能(03696)尾盘涨超3%，截至发稿，涨2.89%，报38.46港元，成交额1.11亿港元。消息面上，1月5日，英硅智能发布公告，集团已与一家由基金会管理的全球独立制药公司施维雅达成多年期研发合作。该合作价值高达8.88亿美元，将充分利用集团自主研发的人工智能平台Pharma.AI，聚焦于抗肿瘤领域具有挑战性的靶点，识别并开发全新的治疗药物。根据协议，集团将有资格获得...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1389237.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 英硅智能(03696)尾盘涨超3% 与施维雅达成多年期抗肿瘤药物研发合作</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 英硅智能(03696)尾盘涨超3% 与施维雅达成多年期抗肿瘤药物研发合作\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-06 15:11 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1389237.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，英硅智能(03696)尾盘涨超3%，截至发稿，涨2.89%，报38.46港元，成交额1.11亿港元。消息面上，1月5日，英硅智能发布公告，集团已与一家由基金会管理的全球独立制药公司施维雅达成多年期研发合作。该合作价值高达8.88亿美元，将充分利用集团自主研发的人工智能平台Pharma.AI，聚焦于抗肿瘤领域具有挑战性的靶点，识别并开发全新的治疗药物。根据协议，集团将有资格获得...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1389237.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1389237.html","article_id":"2601886148","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2601886148","pubTimestamp":1767683517,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，英硅智能尾盘涨超3%，截至发稿，涨2.89%，报38.46港元，成交额1.11亿港元。消息面上，1月5日，英硅智能发布公告，集团已与一家由基金会管理的全球独立制药公司施维雅达成多年期研发合作。值得一提的是，2025年12月30日，英硅智能正式登陆香港联合交易所主板，被市场公认为港股“AI制药第一股”。这两项数据均刷新了年内非18A港股医疗健康IPO的最高认购纪录。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"03696":"英矽智能"},"translate_title":"Changes in Hong Kong stocks | Yingsi Intelligent (03696) rose more than 3% in late trading and reached a multi-year anti-tumor drug research and development cooperation with Servier","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1.5},"content_text":"智通财经APP获悉，英硅智能(03696)尾盘涨超3%，截至发稿，涨2.89%，报38.46港元，成交额1.11亿港元。消息面上，1月5日，英硅智能发布公告，集团已与一家由基金会管理的全球独立制药公司施维雅达成多年期研发合作。该合作价值高达8.88亿美元，将充分利用集团自主研发的人工智能平台Pharma.AI，聚焦于抗肿瘤领域具有挑战性的靶点，识别并开发全新的治疗药物。根据协议，集团将有资格获得最高3,200万美元的首付款及近期研发里程碑付款，并将主导运用人工智能技术平台，发现及开发符合既定标准的潜在候选药物，而施维雅将共同承担研发成本，主导后续临床验证及商业化进程。值得一提的是，2025年12月30日，英硅智能正式登陆香港联合交易所主板，被市场公认为港股“AI制药第一股”。其IPO表现堪称现象级：香港公开发售部分录得约1427倍的超额认购，锁定认购资金逾3283亿港元；国际发售同样反响热烈，录得26.27倍超额认购。这两项数据均刷新了年内非18A港股医疗健康IPO的最高认购纪录。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2601886148","isCrawlerRequest":true}